揚傑科技(300373.SZ):公司越南封測工廠已經開始投入建設中,預計2024年底投入使用
格隆匯10月24日丨揚傑科技(300373.SZ)在投資者互動平台表示,公司持續增強對第三代半導體的研發力度,其中碳化硅系列二極管、MOSFET等系列產品均已經得到多領域國內top客户認可,並實現批量出貨。碳化硅晶圓項目廠房建設已經封頂,設備已經在陸續進場中,相關產品研發也在持續推進,預計2024年可通線量產。公司越南封測工廠已經開始投入建設中,預計2024年底投入使用。屆時公司在產能提升及供應鏈構建上均會有一個新的突破。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.